Top compounds associated with response to LYSMD1


Feature Type Standardized
Nominal ANOVA
mRNA VX-11e GDSC1000 pan-cancer AAC -0.038 0.3
mRNA Docetaxel CTRPv2 pan-cancer AAC 0.057 0.3
mRNA WZ8040 CTRPv2 pan-cancer AAC -0.045 0.3
mRNA WP1130 CTRPv2 pan-cancer AAC 0.041 0.3
mRNA paclitaxel UHNBreast pan-cancer AAC -0.35 0.3
mRNA MI-2 CTRPv2 pan-cancer AAC 0.062 0.3
mRNA NVP-BEZ235 GDSC1000 pan-cancer AAC -0.039 0.3
mRNA BRD-K27224038 CTRPv2 pan-cancer AAC 0.083 0.3
mRNA Sunitinib GDSC1000 pan-cancer AAC -0.059 0.3
mRNA WH-4-023 GDSC1000 pan-cancer AAC -0.057 0.3
Download CSV